Ticagrelor bringt bei PAVK keine Vorteile im Vergleich zur Standardtherapie mit Clopidogrel
暂无分享，去创建一个
[1] S. Johnston,et al. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. , 2016, The New England journal of medicine.
[2] Marc P. Bonaca,et al. Long-term use of ticagrelor in patients with prior myocardial infarction. , 2015, The New England journal of medicine.
[3] D. Clement. A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .